Document is current

Any future updates will be listed below

A randomised Phase I/II trial to evaluate the efficacy and safety of orally administered Oxalobacter formigenes to treat primary hyperoxaluria

Crossref DOI link: https://doi.org/10.1007/s00467-016-3553-8

Published Online: 2016-12-06

Published Print: 2017-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark